Previous close | 305.79 |
Open | 302.48 |
Bid | 294.00 x 900 |
Ask | 301.20 x 800 |
Day's range | 300.31 - 305.32 |
52-week range | 220.20 - 335.33 |
Volume | |
Avg. volume | 2,926,750 |
Market cap | 286.307B |
Beta (5Y monthly) | 0.35 |
PE ratio (TTM) | 48.06 |
EPS (TTM) | 6.27 |
Earnings date | 01 Nov 2022 |
Forward dividend & yield | 3.92 (1.30%) |
Ex-dividend date | 12 Aug 2022 |
1y target est | 304.28 |
Eli Lilly said it would divert employment outside its home state of Indiana following the Republican-controlled legislature’s decision to pass a nearly total ban on abortion. “We are concerned that this law will hinder Lilly’s — and Indiana’s — ability to attract diverse scientific, engineering and business talent from around the world,” said Lilly. The US drugmaker said it had expanded its employee health plan to cover interstate travel for abortion and reproductive services, but added this might not be enough for some current and future staff.
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.